[Bronchopulmonary dysplasia in newborns]].
Published data on the modern state-of-art of bronchopulmonary dysplasia in newborns were analyzed as a complication of prolonged artificial pulmonary ventilation (APV). Agents that can affect an underformed lung in an immature newborn and which can trigger a chronic pathology yet on the 1st month life are under discussion. Modern concepts related with the development of bronchopulmonary dysphasia in newborns after a prolonged APV as well as the key issues of treatment and prevention of the mentioned disease are in the focus of attention.
Smagin
A Iu
AIu
Chernyshev
A K
AK
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001997:Bronchopulmonary Dysplasia / Q000209:etiology / Q000628:therapy; D006801:Humans; D007231:Infant, Newborn; D010102:Oxygen Inhalation Therapy; D011663:Pulmonary Surfactants / Q000008:administration & dosage / Q000627:therapeutic use; D012121:Respiration, Artificial / Q000009:adverse effects*; D012127:Respiratory Distress Syndrome, Newborn / Q000150:complications / Q000628:therapy
D000305:Adrenal Cortex Hormones; D001993:Bronchodilator Agents; D011663:Pulmonary Surfactants